RE: PMJH25 Jan 2021 18:32
PhilG my estimation is based in a bid landing in March 2021.
I believe a major pharmaceutical will want to pay up to a maximum £5 billion. I think they will hope for lower.
At this stage I believe anything over £10 is a good offer for this drug. Yes, like you say it could go on to be worth 10 times that level, but for Synairgen, I think it is a very solid price.
Now if Synairgen can secure pre orders, that adds further value to the company. If pre orders run into the billions then I would have to readjust my targets closer to NUMS top end target of £50.
To be honest I can’t even start to think at that becoming reality. One step at a time. Let’s see positive Phase 2 and Phase3 results. Let’s hear about the dual site stock build. Let’s hear about LOXL2. Let’s see some other countries in Europe, Brazil and India joining our trials. Oh and let’s think about the opportunity of licensing our drug in places like India. Allot of news to come. TR1’s are due and also the US launch of Activ2 (to distance it from trump).
Good luck all. Once the churn is complete we should fly !